Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The year in atherothrombosis.

Sanz J, Moreno PR, Fuster V.

J Am Coll Cardiol. 2012 Sep 4;60(10):932-42. doi: 10.1016/j.jacc.2012.04.045. Review. No abstract available.

2.

The year in atherothrombosis.

Sanz J, Fuster V.

J Am Coll Cardiol. 2011 Aug 16;58(8):779-91. doi: 10.1016/j.jacc.2011.03.052. Review. No abstract available.

3.

Relationship between plasma homocysteine and the morphological and immunohistochemical study of carotid plaques in patients with carotid stenosis over 70%.

Alvarez B, Yugueros X, Fernández E, Luccini F, Gené A, Matas M.

Ann Vasc Surg. 2012 May;26(4):500-5. doi: 10.1016/j.avsg.2011.05.047.

PMID:
22520390
4.

[Prevention of cardiovascular disease].

[No authors listed]

Rev Infirm. 2006 Mar;(119):16-23. Review. French. No abstract available.

PMID:
16625779
5.
6.

Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease.

Cariati A, Piromalli E.

Expert Opin Pharmacother. 2012 Jun;13(9):1223-7. doi: 10.1517/14656566.2012.685161. Review.

PMID:
22607008
7.

Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.

Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.

J Atheroscler Thromb. 2013;20(10):733-42. Epub 2013 Jul 26. No abstract available.

8.

Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

Nordestgaard BG, Zacho J.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):521-4. doi: 10.1016/j.numecd.2009.07.005. Epub 2009 Aug 19. Review.

PMID:
19695857
9.

A few unpleasant facts about atherosclerotic arterial disease in the United States and the world.

Alpert JS.

Am J Med. 2012 Sep;125(9):839-40. doi: 10.1016/j.amjmed.2012.04.031. No abstract available.

PMID:
22938924
10.
11.

Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in the Turkish population.

Tascilar N, Ekem S, Aciman E, Ankarali H, Mungan G, Ozen B, Unal A.

Tohoku J Exp Med. 2009 Aug;218(4):293-300.

12.

Guidelines in the USA, a viewpoint contrary to those guidelines in Europe, Canada, Britain and the International Atherosclerosis Society.

Saraf S, Ray KK.

Curr Opin Lipidol. 2014 Dec;25(6):413-7. doi: 10.1097/MOL.0000000000000129. Review.

PMID:
25268983
13.

Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.

Brækkan SK, Hald EM, Mathiesen EB, Njølstad I, Wilsgaard T, Rosendaal FR, Hansen JB.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):487-91. doi: 10.1161/ATVBAHA.111.237545. Epub 2011 Nov 10.

14.

Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion.

Sodi A, Giambene B, Marcucci R, Sofi F, Bolli P, Abbate R, Prisco D, Menchini U.

Eur J Ophthalmol. 2008 Mar-Apr;18(2):233-8.

PMID:
18320516
15.

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.

Ducrocq G, Wallace JS, Baron G, Ravaud P, Alberts MJ, Wilson PW, Ohman EM, Brennan DM, D'Agostino RB, Bhatt DL, Steg PG; REACH Investigators.

Eur Heart J. 2010 May;31(10):1257-65. doi: 10.1093/eurheartj/ehq021. Epub 2010 Feb 24.

16.
17.

Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

Tehrani S, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, Henriksson P, Wallén NH, Jörneskog G.

Thromb Res. 2010 Sep;126(3):e225-31. doi: 10.1016/j.thromres.2010.05.023. Epub 2010 Jul 15.

PMID:
20637495
18.

Amlodipine + atorvastatin single pill is the most effective choice for primary prevention.

Aalbers J.

Cardiovasc J Afr. 2010 Jul-Aug;21(4):243. No abstract available.

19.

Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion.

Sodi A, Giambene B, Marcucci R, Sofi F, Fedi S, Abbate R, Prisco D, Menchini U.

Retina. 2011 Apr;31(4):724-9. doi: 10.1097/IAE.0b013e3181eef419.

PMID:
21178660
20.

Cardiovascular disease: strategies for risk assessment and modification.

Braun LT.

J Cardiovasc Nurs. 2006 Nov-Dec;21(6 Suppl 1):S20-42; quiz S43-5. Review.

PMID:
17293747

Supplemental Content

Support Center